Select Page

2017 Universal Access & Affordable Medicines Forum of the European Public Health Alliance (EPHA)

GAME CHANGERS

FOR BETTER AND AFFORDABLE MEDICINES FOR EUROPE

Under the auspices of the Bulgarian Ministry of Health

November 21, 2017 • 9AM – 6PM

Martin’s Brussels EU Hotel

Boulevard Charlemagne 80, 1000 Brussels

Expect a day full of stimulating and lively discussions on the hottest topics in the access to medicines debate:

– Incentives in drug development: Towards profiteering or genuine innovation?
– The push for accelerated approvals: Speed and deregulation over patient safety and robust evidence?
– Transparency in pharmaceuticals: Desirable &/or feasible?
– Business strategies, anti-competitive practices & medicines’ shortages: What is the way out?

Thank you for your interest in this event. Due to high demand, registration is now closed. However, register below for updates and to receive the report of the event.  You can still join the discussion on Twitter using #GameChangers   

Programme Overview

Programme

08.45 – 09.15

REGISTRATION AND COFFEE


  09.15 – 09.45

WELCOMING REMARKS


09.45 – 11.15

PANEL 1: Transparency in pharmaceuticals: desirable and/or feasible?

Open discussion moderated by Dr. Deborah Cohen, Investigations Editor, British Medical Journal (BMJ)


  11.30 – 13.00

PANEL 2: Drug development: do the incentives work?

Open discussion moderated by Dr. Deborah Cohen, Investigations Editor, British Medical Journal (BMJ)


 13.45 – 15.15

PANEL 3: The push for accelerated drug approvals: speed and deregulation over patient safety and robust evidence?

Open discussion moderated by Dr. Deborah Cohen, Investigations Editor, British Medical Journal (BMJ)


 15.30 – 17.00

PANEL 4: Business strategies, anti-competitive practices & medicines’ shortages: what is the way out?

Open discussion moderated by Dr. Deborah Cohen, Investigations Editor, British Medical Journal (BMJ)


17.00-18.00

NETWORKING RECEPTION

Speakers

Miroslav Nenkov, Deputy Minister of Health,

Bulgaria

Andrzej Rys

Director Responsible for Health Systems, Medical Products and    Innovation, Directorate-General for Health and Food Safety (DG SANTE), European Commission

 

Dr. Deborah Cohen

 Investigations Editor, British Medical Journal (BMJ)

Boris Azais

Director, Public Policy for Europe and Canada, MSD

Antonio Addis

Researcher, Department of Epidemiology, Regional Health Service, Rome

 

Francis Arickx

 Head, Pharmaceutical Department, National Institute for Health and   Disability  Insurance (RIZIV INAMI), Belgium

Aida Batista

Vice-President, European Association of Hospital Pharmacists (EAHP)

 

Marcel Canoy

Advisor, Netherlands Authority for Consumers and Markets (ACM)

 

Simon Collins

 Patient Advocate, HIV i-Base

 

Aldo Golja

Senior Policy Advisor, Pricing and Reimbursement-Coordinator of the BeNeLuxA Initiative on Pharmaceutical Policy, Ministry of Health, Welfare and Sport, The Netherlands

Dr Andrew Hill

Senior Visiting Research Fellow, Department of Pharmacology and          Therapeutics, Liverpool University

 

Dyfrig Hughes

 Professor of Pharmacoeconomics, School of Healthcare   Sciences, Bangor University, Co-Director, Centre for Health   Economics & Medicines Evaluation

 

Elizabeth Kuiper

Executive Director, Public Affairs, European Federation of Pharmaceutical Industries and Associations, EFPIA

 

Fernando Lamata

Senior Expert on Health Care Policies, Impeller of the Association for a Fair Access to Medicines, Spain

 

Dr Síle Lane

Head, International Campaigns and Policy, Sense about Science,UK

 

Helen Lee

Helen Lee, Unit B5 – Medicines: policy, authorisation and monitoring, DG SANTE, European Commission

Marc-Alexander Mahl

President, Medicines for Europe

 

Els Torreele

Executive Director, Access Campaign, Médecins Sans Frontières (MSF)

 

Vlad Voiculescu

Member, Romanian Health Observatory

 

Beate Wieseler

Head, Department of Drug Assessment, Institute for Quality and Efficiency in Health Care (IQWiG)

 

Claudia Wild

Director, Ludwig Boltzmann Institute for Health Technology Assessment

 

Rainer Becker

Head of Unit for Antitrust Pharma and Health services, Directorate-General for Competition (DG COMP), European Commission

 

Join the #GameChangers

on 21 November

Logistics

Contact

Yannis Natsis

Policy Manager for Universal Access and Affordable Medicines

email

Zlatimira Dobreva

Permanent Representation of the Republic of Bulgaria to the EU | First Secretary Healthcare, Pharmaceutical Products and Medical Devices

email

EPHA in your inbox!

Social Media

Made with love by COCREATE

SUBSCRIBE TO OUR MAILING LIST

We publish our newsletter ten times a year to keep you informed about the latest news on public health in Europe. You can receive it directly in your mailbox.
First Name
Last Name
Email address
Secure and Spam free...